1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Abbott Acquires Bigfoot Biomedical

M&A Deal Summary

Abbott Acquires Bigfoot Biomedical

On September 5, 2023, Abbott acquired medical products company Bigfoot Biomedical

Acquisition Highlights
  • This is Abbott’s 20th transaction in the Medical Products sector.
  • This is Abbott’s 28th transaction in the United States.
  • This is Abbott’s 14th transaction in California.

M&A Deal Summary
Date 2023-09-05
Target Bigfoot Biomedical
Sector Medical Products
Buyer(s) Abbott
Deal Type Add-on Acquisition

Target

Bigfoot Biomedical

Milpitas, California, United States
Bigfoot Biomedical is a health solution company focused on optimizing the care of people with T1D by leveraging data, smart devices and people to deliver improved outcomes valued by patients, providers and payers. Bigfoot Biomedical was founded in 2014 and is based in Milpitas, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 35 of 36
Sector: Medical Products M&A 20 of 20
Type: Add-on Acquisition M&A Deals 35 of 36
State: California M&A 14 of 14
Country: United States M&A 28 of 29
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-08 CSI

St. Paul, Minnesota, United States

CSI is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. CSI was founded in 1989 and is based in St. Paul, Minnesota.

Buy $890M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-11-20 Exact Sciences

Madison, Wisconsin, United States

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

Buy $21.0B
Mergr

Solution for

Product

Company

Legal